Olsson Shawn
Chief Commercial Officer
Olsson Shawn has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2025.
On the most recent filing, Olsson Shawn is listed as Chief Commercial Officer at LENZ Therapeutics, Inc. Inside the rolling window, Olsson Shawn reported no open-market purchases and 1 open-market sale totaling $261K in LENZ.
Companies traded
Other insiders at LENZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$261K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Olsson Shawn made?
Olsson Shawn has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2025.
Which companies does Olsson Shawn trade?
Olsson Shawn has filed SEC Form 4 disclosures for 1 company, including LENZ.
When was Olsson Shawn's most recent SEC Form 4 filing?
Olsson Shawn's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2025.
What is Olsson Shawn's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Olsson Shawn is listed as Chief Commercial Officer.
What is Olsson Shawn's total buy and sell value in the current window?
Inside the rolling retention window, Olsson Shawn bought $0 and sold $261K based on SEC Form 4 filings.
What was Olsson Shawn's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 LENZ shares on 2025-11-17, worth $261K, per SEC Form 4 filings.